Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 3, 2004, Pages 321-327

  Klepper, Jörg ^a   Diefenbach, Sonja ^a   Kohlschütter, Alfried ^b   Voit, Thomas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Acetoacetate; Blood brain barrier; Glucose transport; GLUT1; GLUT1 deficiency syndrome; Hydroxybutyrate; Hypoglycorrhachia; Ketogenic diet; Ketones

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ESSENTIAL FATTY ACID; ETHOSUXIMIDE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 1; KETONE; LACTIC ACID; LIPID; PHENOBARBITAL; VALPROIC ACID;

ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; ENERGY METABOLISM; FEMALE; GLUCOSE TRANSPORT; HUMAN; INFANT; KETOACIDOSIS; KETOGENIC DIET; MALE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SEIZURE;

EID: 1042265013     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.07.004     Document Type: Article

References (39)

1. F. Lefevre, N. Aronson, Ketogenic diet for the treatment of refractory epilepsy in children: systematic review of efficacy, Pediatrics 105 (2000) E46.
2. J.M. Freeman, E.P. Vining, D.J. Pillas, P.L. Pyzik, J.C. Casey, L.M. Kelly, The efficacy of the ketogenic diet-1998: a prospective evaluation of, Pediatrics 102 (1998) 1358-1363.
3. E.P. Vining, J.M. Freeman, K. Ballaban-Gil, et al., A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol. 55 (1998) 1433-1437.
4. P.A. Schwartzkroin, Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet, Epilepsy Res. 37 (1999) 171-180.
5. J.M. Rho, G.D. Anderson, S.D. Donevan, H.S. White, Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo, Epilepsia 43 (2002) 358-361.
6. S.C. Cunnane, K. Musa, M.A. Ryan, S. Whiting, D.D. Fraser, Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet, Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 131-135.
7. D.C. De Vivo, L. Leary, D. Wang, Glucose transporter 1 deficiency syndrome and other glycolytic defects, J. Child Neurol. 17 (2002) 3S15-25.
8. J. Klepper, T. Voit, Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain - a review, Eur. J. Pediatr. 161 (2002) 295-304.
9. J.M. Pascual, R.L. Van Heertum, D. Wang, K. Engelstad, D.C. De Vivo, Imaging the metabolic footprint of Glut1 deficiency on the brain, Ann. Neurol. 52 (2002) 458-464.
10. J. Klepper, M. Willemsen, A. Verrips, et al., Autosomal dominant transmission of GLUT1 deficiency, Hum. Mol. Genet. 10 (2001) 63-68.
11. G. Seidner, M.G. Alvarez, J.I. Yeh, et al., GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier, Nat. Genet. 18 (1998) 188-191.
12. D. Wang, P. Kranz-Eble, D.C. De Vivo, Mutational analysis of GLUT1 (SLC2A1) in GLUT-1 deficiency syndrome, Hum. Mutat. 16 (2000) 224-231.
13. D.F. Nordli Jr., D.C. De Vivo, The ketogenic diet revisited: back to the future, Epilepsia 38 (1997) 743-749.
14. D.C. De Vivo, R.R. Trifiletti, R.I. Jacobson, G.M. Ronen, R.A. Behmand, S.I. Harik, Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay, N. Engl. J. Med. 325 (1991) 703-709.
15. Y.Y. Ho, H. Yang, J. Klepper, J. Fischbarg, D. Wang, D.C. De Vivo, Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro, Pediatr. Res. 50 (2001) 254-260.
16. J. Klepper, J. Fischbarg, J.C. Vera, D. Wang, D.C. De Vivo, GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro, Pediatr. Res. 46 (1999) 677-683.
17. J. Klepper, A. Florcken, J. Fischbarg, T. Voit, Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro, Eur. J. Pediatr. 162 (2003) 84-89.
18. J. Klepper, I. Monden, E. Guertsen, T. Voit, M. Willemsen, K. Keller, Functional consequences of the autosomal dominant G272A mutation in the human GLUT1 gene, FEBS Lett. 498 (2001) 104-109.
19. J. Klepper, J.C. Vera, D.C. De Vivo, Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome, Ann. Neurol. 44 (1998) 286-287.
20. L.D. Leary, D. Wang, D.R. Nordli, K. Engelstad, D.C. De Vivo, Seizure characterization and electroencephalographic features in glut-1 deficiency syndrome, Epilepsia 44 (2003) 701-707.
21. J.M. Freeman, The ketogenic diet and epilepsy, Nestle Nutr. Workshop Ser. Clin. Perform Programme, 2001, pp. 307-318.
22. P. Thavendiranathan, C. Chow, S. Cunnane, W. McIntyre Burnham, The effect of the classic ketogenic diet on animal seizure models, Brain Res. 959 (2003) 206-213.
23. A.S. Dekaban, Plasma lipids in epileptic children treated with the high fat diet, Arch. Neurol. 15 (1966) 177-184.
24. G.F. Cahill, M.G. Herrera, A.P. Morgan, et al., Hormone-fuel interrelationships during fasting, J. Clin. Invest. 45 (1966) 1751-1769.
25. R.L. Leino, D.Z. Gerhart, R. Duelli, B.E. Enerson, L.R. Drewes, Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain, Neurochem. Int. 38 (2001) 519-527.
26. O.E. Owen, G.A. Reichard, G. Boden Jr., C. Shuman, Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation, Metabolism 23 (1974) 7-14.
27. A. Gjedde, C. Crone, Induction processes in blood-brain transfer of ketone bodies during starvation, Am. J. Physiol. 229 (1975) 1165.
28. J.W. Pan, T.L. Rothman, K.L. Behar, D.T. Stein, H.P. Hetherington, Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis, J. Cereb. Blood Flow Metab. 20 (2000) 1502-1507.
29. B. Persson, G. Settergress, G. Dahlquist, Cerebral arterio-venous difference of acetoacetate and D-hydroxybutyrate in children, Acta Paediatr. Scand. 61 (1972) 273-278.
30. H. Kraus, S. Schlenker, D. Schwedesky, Developmental changes of cerebral ketone body utilization in human infants, Hoppe Seylers Z. Physiol. Chem. 355 (1974) 164-170.
31. A.K. Kumagai, Y.S. Kang, R.J. Boado, W.M. Pardridge, Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia, Diabetes 44 (1995) 1399-1404.
32. E.M. Cornford, E.V. Nguyen, E.M. Landaw, Acute upregulation of blood-brain barrier glucose transporter activity in seizures, Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1346-54.
33. R.J. Boado, D. Wu, M. Windisch, In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides, Neurosci. Res. 34 (1999) 217-224.
34. D. De Vivo, M. Garcia-Alvarez, G. Ronen, R. Trifiletti, Glucose transport protein deficiency: an emerging syndrome with therapeutic implications, Int. Pediatr. 10 (1995) 51-56.
35. K.J. Lamers, W.H. Doesburg, F.J. Gabreels, et al., CSF concentration and CSF/blood ratio of fuel related components in children after prolonged fasting, Clin. Chim. Acta 167 (1987) 135-145.
36. J. Edmond, Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport, J. Mol. Neurosci. 16 (2001) 215-221.
37. S.M. Innis, The role of dietary n-6 and n-3 fatty acids in the developing brain, Dev. Neurosci. 22 (2000) 474-480.
38. D.D. Fraser, S. Whiting, R.D. Andrew, E.A. Macdonald, K. Musa-Veloso, S.C. Cunnane, Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet, Neurology 60 (2003) 1026-1029.
39. J. Klepper, B. Leiendecker, R. Bredahl, et al., Introduction of a ketogenic diet in young infants, J. Inher. Metab. Dis. 25 (2002) 449-460.